Alto Neuroscience, Inc. (ANRO)

NYSE: ANRO · IEX Real-Time Price · USD

14.99

-0.38 (-2.47%)

At close: Jul 19, 2024, 4:00 PM

14.00

-0.99 (-6.60%)

Pre-market: Jul 22, 2024, 8:00 AM EDT

Alto Neuroscience Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year Ending	Current	Dec 31, 2023	Dec 31, 2022
Market Capitalization	403	-	-
Enterprise Value	207	-73	-39
PB Ratio	2.09	-	-
EV/EBITDA Ratio	-	2.12	1.43
EV/EBIT Ratio	-	2.08	1.40
EV/FCF Ratio	-	2.14	1.84
Debt / Equity Ratio	0.05	-0.14	-0.25
Debt / EBITDA Ratio	-	-0.29	-0.35
Debt / FCF Ratio	-	-0.29	-0.45
Quick Ratio	25.72	14.72	8.75
Current Ratio	26.02	15.22	8.85
Interest Coverage	-	-25.50	-
Return on Equity (ROE)	-	66.00%	108.90%
Return on Assets (ROA)	-	-52.80%	-69.60%
Return on Capital (ROIC)	-	61.17%	100.87%
Earnings Yield	-10.53%	-	-
Buyback Yield / Dilution	-410.74%	-8.27%	35.80%
Total Shareholder Return	-410.74%	-8.27%	35.80%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).